Henn Matthew R.
Seres Therapeutics, Inc. · See Remarks
Henn Matthew R. is listed in filings as See Remarks at Seres Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Aug 19, 2024 to May 19, 2026. Reported amounts are shown as $580 to $754. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $75489 shares | SellFeb 15, 2026 | $8.47 | $5.33 | |
| $22k1.3k shares | SellNov 15, 2025 | $17.30 | $5.33 | |
| $1.2k73 shares | SellAug 18, 2025 | $16.65 | $5.33 | |
| $56177 shares | SellMay 16, 2025 | $7.28 | $5.33 | |
| $3.2k4k shares | SellFeb 18, 2025 | $0.8104 | $5.33 | |
| $501927 shares | SellNov 18, 2024 | $0.5407 | $5.33 | |
| $2.7k4k shares | SellOct 28, 2024 | $0.6901 | $5.33 | |
| $775923 shares | SellAug 16, 2024 | $0.84 | $5.33 |